Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nyse  >  Marsh & McLennan Companies    MMC

MARSH & MCLENNAN COMPANIES

(MMC)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Strengths
  • The share is getting closer to its long-term support in weekly data, at USD 104.27, which offers good timing for buyers.
  • The close medium term support offers good timing for purchasing the stock.
  • The company returns high margins, thereby supporting business profitability.
  • Considering the small differences between the analysts' various estimates, the group's business visibility is good.
  • Within the weekly time frame the stock shows a bullish technical configuration above the support level at 104.27 USD
Weaknesses
  • The group shows a rather high level of debt in proportion to its EBITDA.
  • With an enterprise value anticipated at 3.57 times the sales for the current fiscal year, the company turns out to be overvalued.
  • For the last four months, the sales outlook for the coming years has been revised downwards. No recovery of the group's activities is yet foreseen.
  • For the last few months, analysts have been revising downwards their earnings forecast.
Ratings chart
Sector Multiline Insurance & Brokers - NEC
1st jan.Capitalisation (M$)Investor Rating
MARSH & MCLENNAN COMPANIES1.06%53 857
ALLIANZ SE-6.39%97 182
CHUBB LIMITED-3.57%71 425
ZURICH INSURANCE GROUP2.09%61 659
AMERICAN INTERNATIONAL GROU..-15.43%39 304
BAJAJ FINSERV1.40%20 869
HARTFORD FINANCIAL SERVICES..-14.50%19 507
BB SEGURIDADE PARTICIPAÇÕES..-12.47%14 346
-
TALANX AG-5.25%11 990
CNP ASSURANCES-17.82%11 362
-
FOSUN INTERNATIONAL LIMITED0.80%11 059
GJENSIDIGE FORSIKRING ASA9.09%10 575
AGEAS SA/NV-16.97%9 412
POWSZECHNY ZAKLAD UBEZPIECZ..0.84%8 146
BÂLOISE-HOLDING-4.34%7 912
ICICI LOMBARD GENERAL INSUR..-4.38%7 830
More Results
Financials (USD)
Sales 2020 17 906 M
EBIT 2020 3 780 M
Net income 2020 2 399 M
Debt 2020 9 981 M
Yield 2020 1,79%
P/E ratio 2020 23,4x
P/E ratio 2021 19,5x
EV / Sales2020 3,57x
EV / Sales2021 3,37x
Capitalization 53 857 M
Upcoming event on MARSH & MCLENNAN COMPANIES
Surperformance© ratings
  Help  
Fundamental ratings
Overall rating
Trading Rating
Investor Rating
Growth (Revenue)
Valuation
Finances
Profitability
Earnings quality
Business Predictability
P/E ratio
Potential
Yield
Consensus
7 days EPS revision
4 months EPS revision
1 year EPS revision
4 months Revenue revision
1 year Revenue revision
Technical ratings
Short Term Timing
Middle Term Timing
Long Term Timing
RSI
Bollinger Spread
Unusual Volumes